Table 10.
Structure and function
| Indication | Appropriateness criteria (median score) | Note | |
|---|---|---|---|
| Morphology | |||
| 35 | Assessment of complex congenital heart disease including anomalies of coronary circulation, great vessels, and cardiac chambers and valves | A (8) | Highly agreed |
| ACCF indication no. 18 | |||
| ASCI CT indication no. 35 | |||
| 36 | Assessment of post-operative congenital heart disease, such as residual pulmonary stenosis, ventricular septal defect and patency check for Blalock-Taussig shunt | A (8) | Highly agreed |
| ASCI CT indication no. 36 | |||
| Asian characteristic indication | |||
| 37 | Evaluation in patients with new onset heart failure to assess etiology | A (8) | Highly agreed |
| ASCI CT indication no. 37 | |||
| Evaluation of ventricular and valvular function | |||
| 38 | Evaluation of LV function following myocardial infarction OR in heart failure patients | A (8) | Highly agreed |
| ACCF indication no. 19 | |||
| 39 | Evaluation of LV function following myocardial infarction OR in heart failure patients | A (9) | Highly agreed |
| ACCF indication no. 20 | |||
| Patients with technically limited images from echocardiogram | |||
| 40 | Quantification of LV function | A(9) | Highly agreed |
| Discordant information that is clinically significant from prior tests | ACCF indication no. 21 | ||
| 41 | Evaluation of specific cardiomyopathies (infiltrative [amyloid, sarcoid], HCM, or due to cardiotoxic therapies) | A(9) | Highly agreed |
| ACCF indication no. 22 | |||
| 42 | Characterization of native and prosthetic cardiac valves | A (7) | Highly agreed |
| Patients with technically limited images from echocardiogram or TEE | ACCF indication no. 23 | ||
| 43 | Evaluation for arrhythmogenic right ventricular cardiomyopathy (ARVC) | A (8) | Highly agreed |
| ACCF indication no. 24 | |||
| Patients presenting with syncope or ventricular arrhythmia | |||
| 44 | Evaluation of myocarditis or myocardial infarction with normal coronary arteries | A(9) | Highly agreed |
| ACCF indication no. 25 | |||
| Positive cardiac enzymes without obstructive atherosclerosis on angiography | |||
| Evaluation of intra- and extra-cardiac structures | |||
| 45 | Evaluation of cardiac mass (suspected tumor or thrombus) | A (9) | Highly agreed |
| Patients with technically limited images from echocardiogram or TEE | ACCF indication no. 26 | ||
| ASCI CT indication no. 42 | |||
| 46 | Evaluation of pericardial conditions (pericardial mass, constrictive pericarditis, or complications of cardiac surgery) | A (8) | Highly agreed |
| Patients with technically limited images from echocardiogram or TEE | |||
| ACCF indication no. 27 | |||
| ASCI CT indication no. 43 | |||
| 47 | Evaluation of pulmonary vein anatomy prior to invasive radiofrequency ablation for atrial fibrillation | A (7) | Highly agreed |
| ACCF indication no. 29 | |||
| Left atrial and pulmonary venous anatomy including dimensions of veins for mapping purposes | |||
| ASCI CT indication no. 44 | |||